JP2001524526A - サイトカインの細胞生産を阻害するための方法 - Google Patents

サイトカインの細胞生産を阻害するための方法

Info

Publication number
JP2001524526A
JP2001524526A JP2000522922A JP2000522922A JP2001524526A JP 2001524526 A JP2001524526 A JP 2001524526A JP 2000522922 A JP2000522922 A JP 2000522922A JP 2000522922 A JP2000522922 A JP 2000522922A JP 2001524526 A JP2001524526 A JP 2001524526A
Authority
JP
Japan
Prior art keywords
group
hydrogen
cells
azo
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000522922A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001524526A5 (https=
Inventor
ゴールドマン，ミシェル
マルジェリー，エレーヌ
アデリン オスカル ロベレッシュ，パトリック
ピエール ロベール ギスラン タシニョン，ジャン
バンドベルド，ミシェル
Original Assignee
プレビザン アクチェンゲゼルシャフト
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by プレビザン アクチェンゲゼルシャフト filed Critical プレビザン アクチェンゲゼルシャフト
Publication of JP2001524526A publication Critical patent/JP2001524526A/ja
Publication of JP2001524526A5 publication Critical patent/JP2001524526A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2000522922A 1997-11-26 1998-11-25 サイトカインの細胞生産を阻害するための方法 Pending JP2001524526A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BE9700949A BE1011571A3 (fr) 1997-11-26 1997-11-26 Procede d'inhibition de la production cellulaire de cytokines.
BE9700949 1997-11-26
PCT/BE1998/000183 WO1999027937A2 (fr) 1997-11-26 1998-11-25 Procede d'inhibition de la production cellulaire de cytokines

Publications (2)

Publication Number Publication Date
JP2001524526A true JP2001524526A (ja) 2001-12-04
JP2001524526A5 JP2001524526A5 (https=) 2006-01-05

Family

ID=3890860

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000522922A Pending JP2001524526A (ja) 1997-11-26 1998-11-25 サイトカインの細胞生産を阻害するための方法

Country Status (10)

Country Link
US (1) US6407081B1 (https=)
EP (1) EP1032401B1 (https=)
JP (1) JP2001524526A (https=)
AT (1) ATE290870T1 (https=)
AU (1) AU757489B2 (https=)
BE (1) BE1011571A3 (https=)
CA (1) CA2312023A1 (https=)
DE (1) DE69829406T2 (https=)
ES (1) ES2241182T3 (https=)
WO (1) WO1999027937A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009515830A (ja) * 2005-10-26 2009-04-16 アシュ−ファール 微粉化アゾジカルボンアミド、その調製及びその使用

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1011571A3 (fr) * 1997-11-26 1999-11-09 Hubriphar Procede d'inhibition de la production cellulaire de cytokines.
AU4545301A (en) * 2000-03-14 2001-09-24 Nat Jewish Med & Res Center Method and composition for treating airway hyperresponsiveness
EP2213299B1 (fr) 2009-01-29 2015-09-09 Michel Vandevelde Composition vaccinale à base de virus exhibant une protéine à motif(s) en doigt de zinc, son procédé de préparation et son utilisation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2060373T3 (es) * 1990-04-19 1994-11-16 Previsan Sa Derivados azoicos, compuestos farmaceuticos y desinfectantes que los contienen y su utilizacion contra el sida.
US5585367A (en) 1990-04-19 1996-12-17 Previsan S.A. Method of treating humans and animals infected with viruses of the retrovirus group
BE1011571A3 (fr) * 1997-11-26 1999-11-09 Hubriphar Procede d'inhibition de la production cellulaire de cytokines.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009515830A (ja) * 2005-10-26 2009-04-16 アシュ−ファール 微粉化アゾジカルボンアミド、その調製及びその使用

Also Published As

Publication number Publication date
EP1032401B1 (fr) 2005-03-16
WO1999027937A2 (fr) 1999-06-10
WO1999027937A3 (fr) 1999-10-14
AU757489B2 (en) 2003-02-20
CA2312023A1 (fr) 1999-06-10
EP1032401A2 (fr) 2000-09-06
AU1327699A (en) 1999-06-16
BE1011571A3 (fr) 1999-11-09
ATE290870T1 (de) 2005-04-15
DE69829406D1 (de) 2005-04-21
US6407081B1 (en) 2002-06-18
ES2241182T3 (es) 2005-10-16
DE69829406T2 (de) 2006-03-02

Similar Documents

Publication Publication Date Title
AU780284B2 (en) Immunosurpressive effects of pteridine derivatives
AU2004251435A1 (en) Inhibitors of histone deacetylases for the SUPPRESSION THERAPY of diseases
SK279521B6 (sk) Použitie rapamicínu
US20030166723A1 (en) Ige production inhibitors
JP3041232B2 (ja) 癌転移抑制剤
JP2025185105A (ja) タンパク質キナーゼ阻害剤としてのヘテロ環化合物の新規塩およびこれらの用途
Cui et al. Boosting regulatory T cell-dependent immune tolerance by activation of p53
JPH05502434A (ja) 医薬組成物およびその用途
JP2023510291A (ja) 幹細胞の機能強化用組成物
US6034100A (en) Method for inhibiting cytokine secretion
JP2001524526A (ja) サイトカインの細胞生産を阻害するための方法
JP2650039B2 (ja) インターロイキン−１の放出を抑制する組成物
EA014070B1 (ru) Применение растительной композиции для лечения воспалительных нарушений
WO1997002822A1 (en) Drug for ameliorating brain diseases
WO2024221689A1 (zh) 一种jak-hadc双靶点抑制剂的应用、治疗炎症性皮肤病药物
US5521185A (en) Methods for inhibiting graft rejection and IL-1 production
KR101581508B1 (ko) 코엔자임 ｑ１０을 유효성분으로 포함하는 염증성 질환 또는 면역거부질환의 예방 또는 치료용 조성물
CN114984011A (zh) 吡咯并吡啶类化合物在制备治疗狼疮药物中的应用
CN114712508A (zh) Pdia3抑制剂在预防和治疗cd4+t细胞主导的相关疾病中的用途
JPH07316051A (ja) 免疫抑制剤としてのベルベリン
US6242415B1 (en) Mediation of cytokines by melanin
Mangal Designing Metabolite-based Therapies to Rewire Immunometabolism and Treat Autoimmune Rheumatoid Arthritis
CN118477178A (zh) 亲脂性他汀在制备预防/治疗自身免疫性疾病的药物中的应用
JPH0344320A (ja) ｐ―［２―（５，６，７，８―テトラヒドロ―５，５，８，８―テトラメチル―２―ナフチル）プロペニル］フエノールの医薬としての使用
US5011857A (en) Method of inhibiting interleukin-1 release

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20050513

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051025

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20051025

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090526

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20091110